ORCA
Online Research @ Cardiff
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 4.
Tahsin, Tasmia, McPhail, Darius K., Champion, Jesse D., Alzahrani, Mohammad A. M., Hilditch, Madeleine L., Faris-Orr, Alexandre, Calver, Brian L., Cronin, James G., Mareque-Rivas, Juan C., Sexton, Darren W., Hughes, Stephen Fôn, Conlan, Robert Steven, Davies, David Mark and Tee, Andrew R.
2025.
Targeting NRF2 and FSP1 to overcome ferroptosis resistance in TSC2-deficient and cancer cells.
Cancers
17
(16)
, 2714.
10.3390/cancers17162714
|
|
|
Jones, Rachel-Ann  ORCID: https://orcid.org/0000-0001-9792-7483, Dunlop, Elaine ORCID: https://orcid.org/0000-0002-9209-7561, Champion, Jesse, Doubleday, Peter F., Claessens, Tijs, Jalali, Zahra, Seifan, Sara, Perry, Iain, Giles, Peter ORCID: https://orcid.org/0000-0003-3143-6854, Harrison, Oliver, Coull, Barry J., Houweling, Arjan C., Pause, Arnim, Ballif, Bryan A. and Tee, Andrew ORCID: https://orcid.org/0000-0002-5577-4631
2025.
Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome through transcriptiomic and proteomic analysis.
Oncogene
44
, pp. 1833-1843.
10.1038/s41388-025-03325-z
|
|
|
Champion, Jesse
2023.
Targeting the REF1/STAT3 axis to treat tuberous sclerosis.
PhD Thesis,
Cardiff University.
Item availability restricted. |
|
|
Champion, Jesse D., Dodd, Kayleigh M., Lam, Hilaire C., Alzahrani, Mohammad A.M., Seifan, Sara, Rad, Ellie, Scourfield, David Oliver, Fishel, Melissa L., Calver, Brian L., Ager, Ann ORCID: https://orcid.org/0000-0002-5763-8908, Henske, Elizabeth P., Davies, D. Mark, Kelley, Mark R. and Tee, Andrew R. ORCID: https://orcid.org/0000-0002-5577-4631
2022.
Drug inhibition of redox factor-1 restores hypoxia-driven changes in tuberous sclerosis complex 2 deficient cells.
Cancers
14
(24)
, 6195.
10.3390/cancers14246195
|
|
|